Sihuan Pharmaceutical (00460) Announces January 2026 Monthly Return

Bulletin Express
Feb 02

Sihuan Pharmaceutical Holdings Group Ltd. (00460) reported that, as of January 31, 2026, the authorized share capital remains at 100,000,000,000 ordinary shares with a par value of HKD 0.01 each, totaling HKD 1,000,000,000. There were no changes from the previous month.

The number of issued shares (excluding treasury shares) remained at 9,145,988,206, and the number of treasury shares stayed at 184,011,000, with no movements during the period. The company confirmed compliance with the applicable public float requirement.

Regarding share options, 60,586,000 options under an exercise price of HKD 0.972 and 7,500,000 options under an exercise price of HKD 2.22 remained outstanding. No new shares were issued or transferred out of treasury shares as a result of the exercise of options during January 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10